DXC Technology Company, together with its subsidiaries, provides information technology services and solutions in the United States, the United Kingdom, rest of Europe, Australia, and internationally. It operates in two segments, Global Business Services (GBS) and Global Infrastructure Services (GIS). The GBS segment offers a portfolio of analytics services and extensive partner ecosystem that help its customers to gain insights, automate operations, and accelerate their transformation journeys; and software engineering, consulting, and data analytics solutions, which enable businesses to run and manage their mission-critical functions, transform their operations, and develop new ways of doing business. This segment also simplifies, modernize, and accelerate mission-critical applications that support business agility and growth through applications services; provides proprietary modular insurance software and platforms; and operates a wide spectrum of insurance business process services, as well as helps to operate and improve bank cards, payment and lending process and operations, and customer experiences. The GIS segment offers security services, such as IT security, operations and culture for migrating to the cloud, protecting data with a zero-trust strategy, and manage a security operation center; and cloud infrastructure and IT outsourcing services. This segment also delivers a consumer-like experience, centralize IT management, and support services, as well as improves the total cost of ownership; and orchestrates hybrid cloud and multicloud environments. The company markets and sells its products through direct sales force to commercial businesses and public sector enterprises. DXC Technology Company was founded in 1959 and is headquartered in Ashburn, Virginia.

DXC Technology Company

Dxc Technology Company (($DXC)) has held its Q3 earnings call. Read on for the main highlights of the call. DXC Technology Balances AI Ambition Wit...

DXC Technology Earnings Call: AI Pivot vs. Revenue Drag

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on DXC Technology (DXC – Research Report) and KLA (KL...

Analysts Offer Insights on Technology Companies: DXC Technology (DXC) and KLA (KLAC)

Dexus Convenience Retail REIT ( ($AU:DXC) ) has issued an update. Dexus Convenience Retail REIT has extended its on-market securities buy-back prog...

Dexus Convenience Retail REIT Extends On-Market Buy-Back for Another Year

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Nurix Therapeutics (NRIX – Research Report) and Dexc...

Analysts’ Top Healthcare Picks: Nurix Therapeutics (NRIX), Dexcom (DXCM)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on BillionToOne, Inc. Class A (BLLN – Research Report) and Dexcom (D...

Analysts Offer Insights on Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Dexcom (DXCM)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX – Research Report),...

Analysts’ Top Healthcare Picks: Praxis Precision Medicines (PRAX), Dexcom (DXCM)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ultragenyx Pharmaceutical (RARE – Research Report), ...

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Dexcom (DXCM) and Health Catalyst (HCAT)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cartesian Therapeutics (RNAC – Research Report), Evo...

Analysts Offer Insights on Healthcare Companies: Cartesian Therapeutics (RNAC), Evolus (EOLS) and Dexcom (DXCM)

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Dexcom on January 7 and set a price target of $85.00. The company’s shares close...

RBC Capital Reaffirms Their Buy Rating on Dexcom (DXCM)

Wolfe Research analyst Darrin Peller maintained a Sell rating on DXC Technology today and set a price target of $14.00. Peller covers the Technolog...

Wolfe Research Remains a Sell on DXC Technology (DXC)

TipRanks offers all of the hottest stock market news for Wednesday in its daily wrap-up.


Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!

Alpha Modus stock rallied on Wednesday after the company revealed a collaboration with DXC Technology.


Current Quarter	$0.69	Next Quarter	$0.63
Current Year	$3.17	Next Year	$3.13
QoQ Growth	-8.7%	YoY Growth	-1.3%
3Y EPS CAGR	-9.2%	Target Price	$14.63
Consensus	Buy	Upside	+8.1%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DXC	$13.54	-11.42%	2.28M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DXC	$13.54	-11.4%	2.28M
3
4
5
6

DXC

DXC

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get DXC Technology Company Data in Excel

Get DXC Technology Company Data in Excel